<DOC>
	<DOCNO>NCT00654355</DOCNO>
	<brief_summary>The purpose research study well understand study drug work people use treat atopic dermatitis .</brief_summary>
	<brief_title>Measuring Adherence Topical Therapy Children With Atopic Dermatitis Impact Return Visit</brief_title>
	<detailed_description>To evaluate adherence topical therapy use adherence data collect MEMS cap ( Medication Electronic Monitoring System ) pediatric patient atopic dermatitis ( AD ) impact return visit .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>1 . Male female subject age 215 . 2 . Stable worsen atopic dermatitis affect 5 % great body surface area . Face genital area include body surface area determination treatment area . 3 . The ability willingness follow study procedure , attend schedule visit , successfully complete study . 4 . The ability understand sign write informed consent/assent form , must obtain prior treatment . 1 . Known allergy tacrolimus component formulation . 2 . The use systemic therapy atopic dermatitis within past 4 week . 3 . Use prescription topical therapy atopic dermatitis ( e.g. , corticosteroid retinoids ) within past 2 week . 4 . Use investigational therapy within past 4 week . 5 . Pregnant female , female breast feeding , females childbearing potential practicing acceptable method birth control ( abstinence , birth control pill/patch , barrier spermicidal jelly , IUD , etc . ) , determine investigator . Acceptable contraception must use entire study . A pregnancy test perform female childbearing potential baseline week 4 . 6 . Any condition , judgment investigator , would put subject unacceptable risk participation study .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>atopic dermatitis</keyword>
	<keyword>eczema</keyword>
</DOC>